Cellebrite DI Ltd. Initial Statement of Beneficial Ownership

Cellebrite DI Ltd. director Nadine Baudot-Trajtenberg filed an initial Form 3 reporting her beneficial ownership in the company.

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Nadine Baudot-Trajtenberg filed an initial Form 3 reporting her beneficial ownership in the company. She reports holding 35,554 Ordinary Shares directly. This total includes 10,601 Ordinary Shares represented by restricted share units granted on September 17, 2025, which vest on September 17, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Baudot-Trajtenberg Nadine

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	--	--	--

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") — 35,554 shares (Direct)

Footnotes (1)

1. F1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 08:19 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Baudot-Trajtenberg Nadine

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	35,554(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

	/s/ Nadine Baudot-Trajtenberg	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)